ArticleActa psychiatrica Scandinavica2026
Perception of ADHD and Compliance in Relation to ADHD Medication.
Article in Acta psychiatrica Scandinavica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionADHD medication has proven effective for treating ADHD in adults. Large registry-based studies have generally reported high discontinuation rates over time and focused on different risk factors, including comorbidity, gender, and socioeconomic status. The present mixed-model study examines self-reported factors related to the discontinuation of ADHD medication in Danish adults. It specifically focuses on themes such as the perception of ADHD and the perceived beneficial and adverse effects of the medication, with the aim of identifying patients' reasons either for continuing or discontinuing the prescribed medication overall and in relation to gender.
objectiveThe present study explores patients' self-reported reasons for continuing or discontinuing ADHD medication, as well as the factors that influence their decision to live with or without medication despite having ADHD.
methodsThe present study employed a mixed-model design and consisted of 1050 Danish adults who redeemed a prescription for ADHD medication for the first time between 2017 and 2019. Questionnaires were distributed by Statistics Denmark to 4748 adults, a representative sample of the 16,284 Danish adults who redeemed a prescription within that period. Discontinuation was defined as a gap of 12 months between redemptions, and questionnaires were sent to an equal number of patients who continued or discontinued ADHD medication. A series of 2 (continuation vs. discontinuation) × 2 (male vs. female) two-way ANOVA was conducted for different main themes, all of which were derived from six patient interviews.
resultsThe patients who continued medical treatment were more likely to perceive ADHD as a biological illness, whereas those who discontinued treatment were more likely to perceive ADHD as an illness constructed by society. Furthermore, patients who continued medical treatment reported that the medication had a more positive influence on their lives, whereas those who discontinued the medication reported experiencing more negative feelings. Finally, males were more likely than females to perceive ADHD as a socially created illness, while females reported higher scores than males for taking ADHD medication for themselves, being able to work or attend school, being social, and being able to enjoy peaceful alone.
conclusionsThe present findings suggest that the perception of ADHD as either a biological or a social construct is central to patients' decisions to continue or discontinue ADHD medication. Moreover, interesting gender differences were found regarding the perception of ADHD and the reasons for taking ADHD medication. From a clinical perspective, these findings underscore the importance of understanding the individual patient's perception of ADHD and highlight the need for relatively close clinical monitoring of patients with ADHD due to their high risk of discontinuing medication.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.